GREY:TSTIF - Post by User
Post by
WickedTuna1on May 10, 2018 2:41pm
363 Views
Post# 28013434
What's changed... Everything!! in 3 points
What's changed... Everything!! in 3 points - Large Seller likely done – w/ the Ninepoint fund conversion completed and latest filing indicating half shrs sold.. I think yesterday’s 3.7M shr day likely attracted the dumping of additional 2m shrs by Ninepoint after ydays’ trading halt (remember this was indiscriminate/ non fundamental selling due to a fund conversion from the PM’s at Sprott that held 4.66 mn shrs, they were fans of the stock and were fired on Feb.15 and fund merged to a lrg cap mandate at Ninepoint.)
- Duo claims labeling is broad! – the duo claims we now have is an industry first and the topic of sterilization is at contentious boiling point. FDA just granted our device an ability to sterilize a broad array of duo scopes (up to 4 lumens.. that’s very broad) given Olympus model only has 3 lumens and has 80% mkt shr alone! So basically better than expected outcome on labeling as the claim covers every model out there pentax, etc. maybe not fuji but expect to see marketing directly to these duo -intensive hospitals and GI suites (new mkt oppty)
- Everything is different today – This approval news is so important. TSO3 now in a stronger position to sell their device (more unique offering today vs. yday), and negotiate on conversations around funding, and signing a new distro w/ Getinge or others… our co’s technology has really finally been acknowledge by the industry… and my sense is that Sales Inbound will pick up as well… as an approval like this has gained attention of leading hospitals that now want to pull forward their decision to purchase a sterilizer.. again de-facto monopoly on being able to mitigate hospital risk from these procedures and keep hospitals out of the newspaper.
Capital/Cash
Funding is keeping investors concerned at the present. My understanding from listening to the cc yday that a plan is in place and desire is strong not to raise equity at these levels. “All funding types on the table” but mgmt. wants to take a prudent approach to raising capital for the sales effort. My sense is revolvers, debt, private equity and other distro partnerships are all being considered as forms of infusion and sounds like we could hear back on a final deal being made at some point soon… potentially removing that overhang so we can get to business of closing deals (we have some visibility on 6or 7 of our own units being placed next quarter out of the 30 quotes we have at moment not counting 200+ leads drummed up at the last conf.). Feels like the dam is about to break! Good luck all...